Compounds > rilmenidine
Page last updated: 2024-08-25

rilmenidine and 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole

rilmenidine has been researched along with 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bousquet, P; Ehrhardt, JD; Feldman, J; Fellmann, L; Gasparik, V; Greney, H; Schann, S1
Agbaba, D; Azzali, E; Costantino, G; Glisic, S; Laurila, JM; Nikolic, K; Perovic, V; Pieroni, M; Radi, M; Scheinin, M; Srdic-Rajic, T; Tassini, S; Veljkovic, N; Vucicevic, J1
Bousquet, P; Bruban, V; Ehrhardt, JD; Estato, V; Feldman, J; Monassier, L; Renard, P; Scalbert, E; Schann, S1

Other Studies

3 other study(ies) available for rilmenidine and 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole

ArticleYear
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.
    Journal of medicinal chemistry, 2015, Jan-22, Volume: 58, Issue:2

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood-Brain Barrier; Drug Discovery; Heart Rate; Imidazoline Receptors; Ligands; Metabolic Syndrome; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship; Sympatholytics

2015
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.
    Bioorganic & medicinal chemistry, 2016, 07-15, Volume: 24, Issue:14

    Topics: Adrenergic alpha-Agonists; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; K562 Cells; Ligands; Molecular Structure; Oxazoles; Receptors, Adrenergic, alpha-2; Rilmenidine

2016
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
    Circulation, 2002, Mar-05, Volume: 105, Issue:9

    Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Cardiovascular System; Cyclopropanes; Drug Synergism; Guanosine 5'-O-(3-Thiotriphosphate); Hypotension; Imidazoles; Injections, Intraventricular; Mice; Mice, Transgenic; Microinjections; Nordefrin; Oxazoles; Pyrroles; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Rilmenidine; Sympathetic Nervous System

2002